ReportsWeb- Cervical Dystonia Global Clinical Trials Review H1 | Seite 3

Jun 05 2017 Revance Reports Additional Positive Week 24 Efficacy Results from RT002 Injectable Phase 2 Cervical Dystonia Trial 30 May 18 2017 Revance Announces Positive Top-Line 24-Week Duration of Effect Results in All Three Cohorts in RT002 Injectable Phase 2 Cervical Dystonia Trial 30 Clinical Trial Profile Snapshots 32 Appendix 69 Abbreviations 69 Definitions 69 Research Methodology 70 Secondary Research 70 About Publisher 71 Contact Us 71 Source 71 Inquire for Report at http://www.reportsweb.com/inquiry&RW0001881633/buying Contact Us: Call: [phone] Email: [email protected]